Review Article| Volume 37, ISSUE 1, P87-102, March 2023

Update on Clostridioides difficile Infection in Older Adults

  • Curtis J. Donskey
    Infectious Diseases Section, Louis Stokes Cleveland Veterans Affairs Medical Center, 10701 East Boulevard, Cleveland, OH 44106.
    Geriatric Research Education and Clinical Center, Cleveland Veterans Affairs Medical Center, Cleveland, OH, USA

    Case Western Reserve University School of Medicine, Cleveland, OH, USA
    Search for articles by this author


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Infectious Disease Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Guh A.Y.
        • Mu Y.
        • Winston L.G.
        • et al.
        Trends in U.S. burden of Clostridioides difficile infection and outcomes.
        N Engl J Med. 2020; 382: 1320-1330
        • Donskey C.J.
        Fluoroquinolone restriction to control fluoroquinolone-resistant Clostridium difficile.
        Lancet Infect Dis. 2017; 17: 353-354
        • Riggs M.M.
        • Sethi A.K.
        • Zabarsky T.F.
        • et al.
        Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.
        Clin Infect Dis. 2007; 45: 992-998
        • Simor A.E.
        • Bradley S.F.
        • Strausbaugh L.J.
        • et al.
        Clostridium difficile in long-term-care facilities for the elderly.
        Infect Control Hosp Epidemiol. 2002; 23: 696-703
        • Marciniak C.
        • Chen D.
        • Stein A.C.
        • et al.
        Prevalence of Clostridium difficile colonization at admission to rehabilitation.
        Arch Phys Med Rehabil. 2006; 87: 1086-1090
        • Guerrero D.M.
        • Nerandzic M.M.
        • Jury L.A.
        • et al.
        Clostridium difficile infection in a Department of Veterans Affairs long-term care facility.
        Infect Control Hosp Epidemiol. 2011; 32: 513-515
        • Pawar D.
        • Tsay R.
        • Nelson D.S.
        • et al.
        Burden of Clostridium difficile infection in long-term care facilities in Monroe County, New York.
        Infect Control Hosp Epidemiol. 2012; 33: 1107-1112
        • Hunter J.C.
        • Mu Y.
        • Dumyati G.K.
        • et al.
        Burden of nursing home-onset Clostridium difficile infection in the United States: Estimates of incidence and patient outcomes.
        Open Forum Infect Dis. 2016; 3: ofv196
        • Jinno S.
        • Kundrapu S.
        • Guerrero D.M.
        • et al.
        Potential for transmission of Clostridium difficile by asymptomatic acute care patients and long-term care facility residents with prior C. difficile infection.
        Infect Control Hosp Epidemiol. 2012; 33: 638-639
        • Bobulsky G.S.
        • Al-Nassir W.N.
        • Riggs M.M.
        • et al.
        Clostridium difficile skin contamination in patients with C. difficile-associated disease.
        Clin Infect Dis. 2008; 46: 447-450
        • Donskey C.J.
        • Kundrapu S.
        • Deshpande A.
        Colonization versus carriage of Clostridium difficile.
        Infect Dis Clin North Am. 2015; 29: 13-28
        • Owens Jr., R.C.
        • Donskey C.J.
        • Gaynes R.P.
        • et al.
        Antimicrobial-associated risk factors for Clostridium difficile infection.
        Clin Infect Dis. 2008; 46: S19-S31
        • Kyne L.
        • Warny M.
        • Qamar A.
        • et al.
        Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
        N Engl J Med. 2000; 342: 390-397
        • Jiang Z.D.
        • DuPont H.L.
        • Garey K.
        • et al.
        A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea.
        Am J Gastroenterol. 2006; 101: 1112-1116
        • Bhutto A.
        • Morley J.E.
        The clinical significance of gastrointestinal changes with aging.
        Curr Opin Clin Nutr Metab Care. 2008; 11: 651-660
        • Hopkins M.J.
        • Macfarlane G.T.
        Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection.
        J Med Microbiol. 2002; 51: 448-454
        • Rea M.C.
        • O'Sullivan O.
        • Shanahan F.
        • et al.
        Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota.
        J Clin Microbiol. 2012; 50: 867-875
        • Borriello S.P.
        • Barclay F.E.
        • Welch A.R.
        Evaluation of the predictive capability of an in-vitro model of colonization resistance to Clostridium difficile infection.
        Microb Ecol Health Dis. 1988; 1: 61-64
        • Peron E.P.
        • Hirsch A.A.
        • Jury L.A.
        • et al.
        Another setting for stewardship: high rate of unnecessary antimicrobial use in a veterans affairs long-term care facility.
        J Am Geriatr Soc. 2013; 61: 289-290
        • Mafi J.N.
        • May F.P.
        • Kahn K.L.
        • et al.
        Low-value proton pump inhibitor prescriptions among older adults at a large academic health system.
        J Am Geriatr Soc. 2019; 67: 2600-2604
        • Polage C.R.
        • Solnick J.V.
        • Cohen S.H.
        Nosocomial diarrhea: Evaluation and treatment of causes other than Clostridium difficile.
        Clin Infect Dis. 2012; 55: 982-989
        • Kundrapu S.
        • Sunkesula V.
        • Tomas M.
        • et al.
        Response to Prior and Fitzpatrick.
        Infect Control Hosp Epidemiol. 2016; 37: 362-363
        • Curry S.R.
        • Muto C.A.
        • Schlackman J.L.
        • et al.
        Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.
        Clin Infect Dis. 2013; 57: 1094-1102
        • Longtin Y.
        • Paquet-Bolduc B.
        • Gilca R.
        • et al.
        Effect of detecting and isolating C difficile carriers at hospital admission on the incidence of C difficile infections: A quasi-experimental controlled study.
        JAMA Intern Med. 2016; 176: 796-804
        • Blixt T.
        • Gradel K.O.
        • Homann C.
        • et al.
        Asymptomatic carriers contribute to nosocomial Clostridium difficile infection: A cohort study of 4508 patients.
        Gastroenterol. 2017; 152: 1031-1041
        • Donskey C.J.
        • Sunkesula V.C.K.
        • Stone N.D.
        • et al.
        Transmission of Clostridium difficile from asymptomatically colonized or infected long-term care facility residents.
        Infect Control Hosp Epidemiol. 2018; 39: 909-916
      1. Lucado J, Gould C, Elixhauser A. Clostridium difficile Infections (CDI) in Hospital Stays, 2009 - Healthcare Cost and Utilization Project (HCUP) Statistical Briefs - NCBI Bookshelf.

        • Lessa F.C.
        • Mu Y.
        • Bamberg W.M.
        • et al.
        Burden of Clostridium difficile infection in the United States.
        N Engl J Med. 2015; 372: 825-834
        • Ponnada S.
        • Guerrero D.M.
        • Jury L.A.
        • et al.
        Acquisition of Clostridium difficile colonization and infection after transfer from a Veterans Affairs Hospital to an affiliated long-term care facility.
        Infect Control Hosp Epidemiol. 2017; 38: 1070-1076
        • Dingle K.E.
        • Didelot X.
        • Quan T.P.
        • et al.
        Effects of control interventions on Clostridium difficile infection in England: an observational study.
        Lancet Infect Dis. 2017; 17: 411-421
        • Silva S.Y.
        • Wilson B.M.
        • Redmond S.N.
        • et al.
        Inpatient fluoroquinolone use in Veterans' Affairs hospitals is a predictor of Clostridioides difficile infection due to fluoroquinolone-resistant ribotype 027 strains.
        Infect Control Hosp Epidemiol. 2021; 42: 57-62
        • Weiner-Lastinger L.M.
        • Pattabiraman V.
        • Konnor R.Y.
        • et al.
        The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network.
        Infect Control Hosp Epidemiol. 2022; 43: 12-25
        • Hensgens M.P.
        • Goorhuis A.
        • Dekkers O.M.
        • et al.
        Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics.
        J Antimicrob Chemother. 2012; 67: 742-748
        • Koo H.L.
        • Ajami N.J.
        • Jiang Z.D.
        • et al.
        A nosocomial outbreak of Norovirus infection masquerading as CDI.
        Clin Infect Dis. 2009; 48: e75-e77
        • Pepin J.
        • Routhier S.
        • Gagnon S.
        • et al.
        Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada.
        Clin Infect Dis. 2006; 42: 758-764
        • Garey K.W.
        • Aitken S.L.
        • Gschwind L.
        • et al.
        Development and validation of a Clostridium difficile health-related quality-of-life questionnaire.
        J Clin Gastroenterol. 2016; 50: 631-637
        • McDonald L.C.
        • Gerding D.N.
        • Johnson S.
        • et al.
        Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).
        Clin Infect Dis. 2018; 66: 987-994
        • Polage C.R.
        • Gyorke C.E.
        • Kennedy M.A.
        • et al.
        Overdiagnosis of Clostridium difficile infection in the molecular test era.
        JAMA Intern Med. 2015; 175: 1792-1801
        • Planche T.
        • Wilcox M.H.
        Diagnostic pitfalls in Clostridium difficile infection.
        Infect Dis Clin North Am. 2015; 29: 63-82
        • Guerrero D.M.
        • Chou C.
        • Jury L.A.
        • et al.
        Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin.
        Clin Infect Dis. 2011; 53: 287-290
        • Miller R.
        • Morillas J.A.
        • Brizendine K.D.
        • et al.
        Predictors of Clostridioides difficile infection-related complications and treatment patterns among nucleic acid amplification test-positive/toxin enzyme immunoassay-negative patients.
        J Clin Microbiol. 2020; 58 (e01764-19)
        • Alonso C.D.
        • Kelly C.P.
        • Garey K.W.
        • et al.
        Ultrasensitive and quantitative toxin measurement correlates with baseline severity, severe outcomes, and recurrence among hospitalized patients with Clostridioides difficile infection.
        Clin Infect Dis. 2022; 74: 2142-2149
        • Sethi A.K.
        • Al-Nassir W.N.
        • Nerandzic M.M.
        • et al.
        Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection.
        Infect Control Hosp Epidemiol. 2010; 31: 21-27
        • Kundrapu S.
        • Sunkesula V.C.
        • Jury L.A.
        • et al.
        Utility of perirectal swab specimens for diagnosis of Clostridium difficile infection.
        Clin Infect Dis. 2012; 55: 1527-1530
        • Kundrapu S.
        • Jury L.A.
        • Sitzlar B.
        • et al.
        Easily modified factors contribute to delays in diagnosis of Clostridium difficile infection: a cohort study and intervention.
        J Clin Microbiol. 2013; 51: 2365-2370
        • Quinn L.K.
        • Chen Y.
        • Herwaldt L.A.
        Infection control policies and practices for Iowa long-term care facility residents with Clostridium difficile infection.
        Infect Control Hosp Epidemiol. 2007; 28: 1228-1232
        • Johnson S.
        • Lavergne V.
        • Skinner A.M.
        • et al.
        Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults.
        Clin Infect Dis. 2021; 73: 755-757
        • Kelly C.R.
        • Fischer M.
        • Allegretti J.R.
        • et al.
        ACG clinical guidelines: Prevention, diagnosis, and treatment of Clostridioides difficile infections.
        Am J Gastroenterol. 2021; 116: 1124-1147
        • Louie T.J.
        • Miller M.A.
        • Mullane K.M.
        • et al.
        Fidaxomicin versus vancomycin for Clostridium difficile infection.
        N Engl J Med. 2011; 364: 422-431
        • Guery B.
        • Menichetti F.
        • Anttila V.J.
        • et al.
        Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.
        Lancet Infect Dis. 2018; 18: 296-307
        • Sunkesula V.C.
        • Kundrapu S.
        • Muganda C.
        • et al.
        Does empirical Clostridium difficile infection (CDI) therapy result in false-negative CDI diagnostic test results?.
        Clin Infect Dis. 2013; 57: 494-500
        • Van Nood E.
        • Vrieze A.
        • Nieuwdorp M.
        • et al.
        Duodenal infusion of donor feces for recurrent Clostridium difficile.
        N Engl J Med. 2013; 368: 407-415
        • Hecker M.T.
        • Obrenovich M.E.
        • Cadnum J.L.
        • et al.
        Fecal Microbiota Transplantation by Freeze-Dried Oral Capsules for Recurrent Clostridium difficile Infection.
        Open Forum Infect Dis. 2016; 3: ofw091
        • Du C.
        • Luo Y.
        • Walsh S.
        • et al.
        Oral fecal microbiota transplant capsules are safe and effective for recurrent Clostridioides difficile infection: a systematic review and meta-analysis.
        J Clin Gastroenterol. 2021; 55: 300-308
        • Rosero C.
        • Donskey C.J.
        • Hecker M.T.
        Long-term follow-up after fecal microbiota transplantation via colonoscopy or freeze-dried capsules for recurrent Clostridioides difficile infection.
        Open Forum Infect Dis. 2021; 8: S599
        • Wilcox M.H.
        • McGovern B.H.
        • Hecht G.A.
        The efficacy and safety of fecal microbiota transplant for recurrent Clostridium difficile infection: current understanding and gap analysis.
        Open Forum Infect Dis. 2020; 7: ofaa114
        • Feuerstadt P.
        • Louie T.J.
        • Lashner B.
        • et al.
        SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.
        N Engl J Med. 2022; 386: 220-229
        • Soriano M.M.
        • Danziger L.H.
        • Gerding D.N.
        • et al.
        Novel fidaxomicin treatment regimens for patients with multiple Clostridium difficile infection recurrences that are refractory to standard therapies.
        Open Forum Infect Dis. 2014; 1: ofu069
        • Sharp D.
        • Palmore T.
        • Grady C.
        The ethics of empowering patients as partners in healthcare-associated infection prevention.
        Infect Control Hosp Epidemiol. 2014; 35: 307-309
        • DeBenedictus C.M.
        • Hecker M.T.
        • Zuccaro P.D.
        • et al.
        What is the current state of patient education after Clostridioides difficile infection?.
        Infect Control Hosp Epidemiol. 2020; 41: 1338-1340
        • Kundrapu S.
        • Sunkesula V.
        • Jury I.
        • et al.
        A randomized trial of soap and water hand wash versus alcohol hand rub for removal of Clostridium difficile spores from hands of patients.
        Infect Control Hosp Epidemiol. 2014; 35: 204-206
        • Hecker M.T.
        • Ho E.
        • Donskey C.J.
        Fear of failure: Engaging patients in antimicrobial stewardship after fecal transplantation for recurrent Clostridium difficile infection.
        Infect Control Hosp Epidemiol. 2017; 38: 127-129
        • Hecker M.T.
        • Aron D.C.
        • Patel N.P.
        • et al.
        Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity.
        Arch Intern Med. 2003; 163: 972-978
        • Hecker M.T.
        • Son A.H.
        • Alhmidi H.
        • et al.
        Efficacy of a stewardship intervention focused on reducing unnecessary use of non-Clostridioides difficile antibiotics in patients with Clostridioides difficile infection.
        Infect Control Hosp Epidemiol. 2020; 41: 216-218
        • Xu D.
        • Mana T.S.C.
        • Cadnum J.L.
        • et al.
        Why Does Doxycycline Pose a Relatively Low Risk for Promotion of Clostridioides difficile Infection?.
        Pathog Immun. 2022; 7: 81-94